PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE)
Status:
Active, not recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
In this feasibility study, a zirconium-89 (89Zr)-avelumab positron emission tomography (PET)
scan will be performed in 37 patients prior to treatment with avelumab to:
1. assess the tumor and systemic tissue uptake 89Zr-avelumab
2. assess the potential to predict avelumab treatment response